Canton Strategic Holdings (CNTN) Operating Expenses (2021 - 2026)
Canton Strategic Holdings' (CNTN) quarterly Operating Expenses came in at $36.9 million in Q1 2026, up 1347.71% YoY from $2.5 million in Q1 2025, and up 170.8% on a QoQ basis from $13.6 million in Q4 2025.
Canton Strategic Holdings (CNTN) Operating Expenses (2021 - 2026) Analysis & Trends
Canton Strategic Holdings (CNTN) has 6 years of Operating Expenses data on file, last reported at $36.9 million in Q1 2026.
- Quarterly Operating Expenses rose 1347.71% year-over-year to $36.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $54.4 million (up 330.83% YoY) and the FY2025 annual result came in at $20.1 million, up 61.71% from the prior year.
- Operating Expenses rose to $36.9 million in Q1 2026, from $13.6 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $36.9 million in Q1 2026 to a low of $1.4 million in Q1 2022.
- A 5-year average of $5.0 million and a median of $2.4 million in 2023 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses jumped 1638.74% — and 2025, when it plunged 45.84%.
- Tracing CNTN's Operating Expenses over 5 years: stood at $1.8 million in 2022, then soared by 43.29% to $2.5 million in 2023, then soared by 52.0% to $3.8 million in 2024, then soared by 253.86% to $13.6 million in 2025, then surged by 170.8% to $36.9 million in 2026.
- The last three Operating Expenses figures came in at $36.9 million (Q1 2026), $13.6 million (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Canton Strategic Holdings | 419.57 Mn | 419.57 Mn | - | 36.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.87 Mn |
| Dec 31, 2025 | 13.61 Mn |
| Sep 30, 2025 | 2.09 Mn |
| Jun 30, 2025 | 1.85 Mn |
| Mar 31, 2025 | 2.55 Mn |
| Dec 31, 2024 | 3.85 Mn |
| Sep 30, 2024 | 3.87 Mn |
| Jun 30, 2024 | 2.37 Mn |
| Mar 31, 2024 | 2.35 Mn |
| Dec 31, 2023 | 2.53 Mn |
| Sep 30, 2023 | 1.85 Mn |
| Jun 30, 2023 | 2.36 Mn |
| Mar 31, 2023 | 2.71 Mn |
| Dec 31, 2022 | 1.77 Mn |
| Sep 30, 2022 | 2.13 Mn |
| Jun 30, 2022 | 1.64 Mn |
| Mar 31, 2022 | 1.35 Mn |
| Dec 31, 2021 | 101,593.00 |
| Sep 30, 2021 | 541,113.00 |
| Jun 30, 2021 | 1.10 Mn |